You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,492,384


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,492,384 protect, and when does it expire?

Patent 9,492,384 protects VERDESO and is included in one NDA.

This patent has twenty-two patent family members in sixteen countries.

Summary for Patent: 9,492,384
Title:Microemulsion and sub-micron emulsion process and compositions
Abstract: An oil in water microemulsion or sub-micron emulsion composition for dermal delivery of desonide is provided, along with a method of medical or cosmetic treatment of a dermal condition using the composition. The composition includes desonide; an oil phase dispersed throughout a water phase, the oil phase including at least one member selected from the group consisting of an animal oil, a mineral oil, a vegetable oil, a silane member, a siloxane, an ester, a fatty acid, a fat, a halogen compound, and an alkoxylated alcohol; and at least one lipophilic surfactant, the water phase including at least one hydrophilic surfactant and water; and a non-surfactant amphiphilic compound that is miscible in the water phase and added to the composition after formation of the microemulsion or sub-micron emulsion; wherein the desonide is in the water phase or both the water phase and the oil phase.
Inventor(s): Larm; Maria Graziella (Rosanna, AU), Harding; Ronald (North Warrandyte, AU), Johnston; Michael (Yarraville, AU), Abram; Albert Zorko (Wantirna, AU), Viyayakumar; Prema (Fremont, CA), Sun; Phoebe (Mountain View, CA)
Assignee: STIEFEL WEST COAST LLC (Wilmington, DE)
Application Number:14/630,592
Patent Claim Types:
see list of patent claims
Composition; Delivery; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis

Introduction to U.S. Patents

A U.S. patent, issued by the United States Patent and Trademark Office (USPTO), grants the inventor an exclusive right to make, use, or sell the invention in the United States for a limited time period. This right also prohibits others from importing the invention into the U.S.[4].

Types of U.S. Patents

There are three primary types of patents in the United States:

  • Utility Patents: These are the most common type and cover functional inventions, such as machines, processes, and compositions of matter.
  • Design Patents: These patents protect new, original, and ornamental designs for articles of manufacture.
  • Plant Patents: These are granted for new and distinct plant varieties[4].

The Patenting Process

The journey to obtaining a U.S. patent involves several key steps:

  • Provisional Patent Application: This is often the first step, providing a one-year period to decide whether to pursue a non-provisional patent application. The provisional application must be inventive, enabled, and not at risk of public disclosure or invention by others[2].
  • Non-Provisional Patent Application: If decided to proceed, a non-provisional patent application is filed, starting the national phase. This application is reviewed by a patent examiner for patentability[2].

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims of the patent, which are the legally binding descriptions of the invention.

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, including:

  • Independent Claim Length: Longer claims often indicate broader scope.
  • Independent Claim Count: More claims can suggest a wider scope of protection[3].

Importance of Claim Language

The language used in patent claims is crucial. Narrower claims are often associated with a higher probability of grant and a shorter examination process. The examination process typically narrows the scope of patent claims, making them more specific and less broad[3].

Patent Claims and Their Construction

Claim Construction

Claim construction is the process of interpreting the meaning of the claims in a patent. This is a question of law and is reviewed de novo on appeal. The courts aim to understand the inventor's intent as expressed in the claims and the specification of the patent[5].

Claim Indefiniteness

Claims must be definite and clear. Indefiniteness is a legal conclusion that can invalidate a patent if the claims do not clearly define the scope of the invention. This is also reviewed de novo on appeal[5].

Patent Landscape and Validity

Presumption of Validity

U.S. patents are accompanied by a presumption of validity. This means that the patent is assumed to be valid unless proven otherwise by clear and convincing evidence[5].

Challenges and Appeals

If a patent application is rejected, the applicant can appeal the decision to an appeal board or the U.S. court system. Successful appeals can lead to claim allowance and the issuance of a patent, while unsuccessful appeals may result in the abandonment of the patent application[2].

Case Study: United States Patent 9,492,384

To illustrate the concepts discussed, let's consider a hypothetical analysis of United States Patent 9,492,384, though the specific details of this patent are not provided here.

Claim Analysis

  • Claim Construction: The claims of the patent would be analyzed to determine their scope and meaning. This involves understanding the inventor's intent and the specific language used in the claims.
  • Claim Indefiniteness: The claims would be reviewed to ensure they are definite and clear, avoiding any ambiguity that could lead to indefiniteness.

Patent Scope

  • Metrics: The independent claim length and count would be analyzed to gauge the breadth of the patent's scope.
  • Examination Process: The history of the patent's examination process would be reviewed to see how the claims were narrowed or broadened during the prosecution phase.

Patent Landscape

  • Prior Art: A search would be conducted to identify any prior art that could affect the patent's validity.
  • Competitor Patents: The landscape of similar patents in the same field would be analyzed to understand the competitive environment.

Costs and Commercial Considerations

Filing and Prosecution Costs

The cost of drafting and filing a U.S. non-provisional patent application can range from $8,000 to $20,000, with additional costs incurred during the prosecution process. International patents can be significantly more expensive[2].

Commercial Partnerships

Commercial partners may cover the costs of patenting if they see potential commercial value in the invention. Even without a commercial partner, the costs may be incurred if there is a reasonable likelihood of recovery from future partnerships[2].

Key Takeaways

  • Patent Scope: Determined by the claims, which must be clear and definite.
  • Claim Construction: A legal process reviewed de novo on appeal.
  • Patent Landscape: Includes prior art, competitor patents, and the broader intellectual property environment.
  • Costs: Significant, with potential for commercial partners to cover costs.
  • Validity: Patents are presumed valid unless proven otherwise.

FAQs

What is the purpose of a provisional patent application?

A provisional patent application provides a one-year period to decide whether to pursue a non-provisional patent application, allowing time to refine the invention and assess its commercial potential[2].

How are patent claims constructed and interpreted?

Claim construction is a legal process that involves interpreting the meaning of the claims in a patent. This is reviewed de novo on appeal to ensure the claims are clear and definite[5].

What metrics are used to measure patent scope?

Independent claim length and independent claim count are simple metrics used to measure patent scope, providing insights into the breadth and depth of protection[3].

Why is the examination process important for patent scope?

The examination process narrows the scope of patent claims, making them more specific and less broad, which can affect the probability of grant and the duration of the examination process[3].

Can a patent be invalidated due to indefiniteness?

Yes, if the claims of a patent are deemed indefinite, the patent can be invalidated. Indefiniteness is a legal conclusion reviewed de novo on appeal[5].

Sources

  1. U.S. Patent and Trademark Office (USPTO) | USAGov
  2. Intellectual Property Protection - KU Office of Research
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. United States Patents: Collections - NYS Library
  5. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,492,384

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Almirall VERDESO desonide AEROSOL, FOAM;TOPICAL 021978-001 Sep 19, 2006 DISCN Yes No 9,492,384 ⤷  Subscribe Y TREATMENT OF ATOPIC DERMATITIS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,492,384

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 051197 ⤷  Subscribe
Australia 2005279704 ⤷  Subscribe
Brazil PI0514806 ⤷  Subscribe
Canada 2578594 ⤷  Subscribe
Canada 2756674 ⤷  Subscribe
China 101048136 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.